Are you an ASCO Member? Note: ASCO membership is not required to participate in this network. Those claiming ASCO membership will be verified.
In Practice with ASCO Member
Please tell us which category best describes you.
Office Staff
Please tell us a little about your experience with EHRs. Are you learning, implementing, or a current EHR user? How can the Oncology EHR Social Network help you? Detailed answers usually get quicker membership approvals.
In my previous role at US Oncology, I had responsibility for the management of the wholly-owned software company, iKnowMed, which is an oncology specific EMR currently rolled out to approx 2/3rd of the USON network. In my new role at UPMC, I have responsibility for the development of the Oncology Information System.
I have read, understand and agree to the the Oncology EHR social network terms and conditions linked to from the main page.
Yes
Comment Wall (2 comments)
You need to be a member of Oncology EHR to add comments!
Dear Kathy Lokay
I listened with great (!) interest to your lecture at ASCO 2009 at the education session «Principles of Safe Practice». MY QUESTION: Did you publish what you said there in a journal? If so, please send me the citation. If not, please inform me when you intend to publish. The medical university here in Salzburg was extremely interested when I informed the professor about what I heard from you at ASCO 2009. Please feel free to contact me anytime, and thank you for your lecture
Kind regards
Dara
Dara Koper, Head, Medical Affairs and Pharmacovigilance, Actavis GmbH, Austria, and Actavis Switzerland AG, E-mail: dkoper@actavis.com, Fax: 00 43 662 435235 01, Telephone: 00 43 662 435235 15, Mobile phone: 00 43 664 8547092
Comment Wall (2 comments)
You need to be a member of Oncology EHR to add comments!
Join Oncology EHR
I listened with great (!) interest to your lecture at ASCO 2009 at the education session «Principles of Safe Practice». MY QUESTION: Did you publish what you said there in a journal? If so, please send me the citation. If not, please inform me when you intend to publish. The medical university here in Salzburg was extremely interested when I informed the professor about what I heard from you at ASCO 2009. Please feel free to contact me anytime, and thank you for your lecture
Kind regards
Dara
Dara Koper, Head, Medical Affairs and Pharmacovigilance, Actavis GmbH, Austria, and Actavis Switzerland AG, E-mail: dkoper@actavis.com, Fax: 00 43 662 435235 01, Telephone: 00 43 662 435235 15, Mobile phone: 00 43 664 8547092